Australia markets closed

Marinus Pharmaceuticals, Inc. (MRNS)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.44000.0000 (0.00%)
At close: 04:00PM EDT
1.4396 -0.00 (-0.03%)
After hours: 07:28PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 79.10M
Enterprise value 2.56M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.50
Price/book (mrq)4.72
Enterprise value/revenue 0.08
Enterprise value/EBITDA -0.02

Trading information

Stock price history

Beta (5Y monthly) 0.89
52-week change 3-82.73%
S&P500 52-week change 322.64%
52-week high 311.2600
52-week low 31.1100
50-day moving average 37.8755
200-day moving average 38.1566

Share statistics

Avg vol (3-month) 31.74M
Avg vol (10-day) 38.44M
Shares outstanding 554.93M
Implied shares outstanding 655.31M
Float 838.28M
% held by insiders 10.97%
% held by institutions 1106.80%
Shares short (28 Mar 2024) 43.47M
Short ratio (28 Mar 2024) 46.33
Short % of float (28 Mar 2024) 46.41%
Short % of shares outstanding (28 Mar 2024) 46.36%
Shares short (prior month 29 Feb 2024) 43.43M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 323 Sept 2020
Ex-dividend date 4N/A
Last split factor 21:4
Last split date 323 Sept 2020

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-492.86%

Management effectiveness

Return on assets (ttm)-38.19%
Return on equity (ttm)-213.02%

Income statement

Revenue (ttm)30.99M
Revenue per share (ttm)0.58
Quarterly revenue growth (yoy)0.40%
Gross profit (ttm)N/A
EBITDA -126.13M
Net income avi to common (ttm)-141.4M
Diluted EPS (ttm)-2.6300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)150.29M
Total cash per share (mrq)2.75
Total debt (mrq)110.36M
Total debt/equity (mrq)658.26%
Current ratio (mrq)4.07
Book value per share (mrq)0.31

Cash flow statement

Operating cash flow (ttm)-118M
Levered free cash flow (ttm)-70.09M